Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer
Adverum Biotechnologies, Inc. REDWOOD CITY, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, today announced that Romuald “Romu” Co...